[go: up one dir, main page]

NO20015614L - Transdermalt terapeutisk system (TTS) som inneholder tolterodin - Google Patents

Transdermalt terapeutisk system (TTS) som inneholder tolterodin

Info

Publication number
NO20015614L
NO20015614L NO20015614A NO20015614A NO20015614L NO 20015614 L NO20015614 L NO 20015614L NO 20015614 A NO20015614 A NO 20015614A NO 20015614 A NO20015614 A NO 20015614A NO 20015614 L NO20015614 L NO 20015614L
Authority
NO
Norway
Prior art keywords
tts
therapeutic system
transdermal therapeutic
tolterodine
containing tolterodine
Prior art date
Application number
NO20015614A
Other languages
English (en)
Other versions
NO20015614D0 (no
Inventor
Christoph Arth
Claus Meese
Dietrich Wilhelm Schacht
Hans-Michael Wolff
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of NO20015614L publication Critical patent/NO20015614L/no
Publication of NO20015614D0 publication Critical patent/NO20015614D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20015614A 1999-05-18 2001-11-16 Transdermalt terapeutisk system (TTS) som inneholder tolterodin NO20015614D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19922662A DE19922662C1 (de) 1999-05-18 1999-05-18 Transdermales therapeutisches System (TTS) Tolterodin enthaltend
PCT/EP2000/004360 WO2000069421A2 (de) 1999-05-18 2000-05-16 Transdermales therapeutisches system (tts) tolterodin enthaltend

Publications (2)

Publication Number Publication Date
NO20015614L true NO20015614L (no) 2001-11-16
NO20015614D0 NO20015614D0 (no) 2001-11-16

Family

ID=7908327

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015614A NO20015614D0 (no) 1999-05-18 2001-11-16 Transdermalt terapeutisk system (TTS) som inneholder tolterodin

Country Status (19)

Country Link
US (1) US6783769B1 (no)
EP (1) EP1178782B1 (no)
JP (1) JP2002544222A (no)
CN (1) CN1356894A (no)
AT (1) ATE335469T1 (no)
AU (1) AU772648B2 (no)
BR (1) BR0010618A (no)
CA (1) CA2373629A1 (no)
DE (2) DE19922662C1 (no)
DK (1) DK1178782T3 (no)
ES (1) ES2270832T3 (no)
HK (1) HK1047703A1 (no)
MX (1) MXPA01011536A (no)
NO (1) NO20015614D0 (no)
PL (1) PL352057A1 (no)
PT (1) PT1178782E (no)
RU (1) RU2251413C2 (no)
WO (1) WO2000069421A2 (no)
ZA (1) ZA200108147B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE19932651A1 (de) * 1999-07-13 2001-01-18 Hexal Ag Transdermales therapeutisches System zur Anwendung von Tolterodin
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
AU2002308612B2 (en) 2001-05-01 2008-04-10 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
ATE502657T1 (de) 2001-05-01 2011-04-15 Av Topchiev Inst Petrochemical Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
JP5594925B2 (ja) 2004-01-30 2014-09-24 コリウム インターナショナル， インコーポレイテッド 活性物質の送達のための急速に溶解するフィルム
JP5270158B2 (ja) 2004-08-05 2013-08-21 コリウム インターナショナル， インコーポレイテッド 粘着性組成物
CN1795845B (zh) * 2004-12-23 2010-10-13 李又欣 作为毒蕈碱受体拮抗剂的3，3-二苯基丙胺衍生物注射用缓释微球制剂
JP2007527923A (ja) * 2005-01-10 2007-10-04 テバ ファーマシューティカル インダストリーズ リミティド トルテロジンタルトレートの調製方法
CA2596529C (en) * 2005-01-27 2014-08-19 Corium International, Inc. Hydrophilic biocompatible adhesive formulations and uses
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
WO2009126844A2 (en) * 2008-04-09 2009-10-15 Concert Pharmaceuticals Inc. Derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof
US20090297591A1 (en) * 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
CA2751884C (en) 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
KR20110001103A (ko) * 2009-06-29 2011-01-06 에스케이케미칼주식회사 보관 안정성이 향상된 톨테로딘 함유 경피 투여 조성물
KR101746204B1 (ko) * 2010-02-18 2017-06-13 에스케이케미칼주식회사 피부 투과가 개선된 톨테로딘의 경피 투여용 조성물
TWI507193B (zh) * 2010-03-30 2015-11-11 Phosphagenics Ltd 經皮輸送貼劑
JP2012051875A (ja) * 2010-08-03 2012-03-15 Hisamitsu Pharmaceut Co Inc 経皮・経粘膜吸収製剤の保存方法及び経皮・経粘膜吸収製剤包装体
JP5642790B2 (ja) * 2010-08-03 2014-12-17 久光製薬株式会社 貼付剤及びその粘着力増強方法
ES2647516T3 (es) 2011-12-12 2017-12-22 Lts Lohmann Therapie-Systeme Ag Sistema de administración transdérmica que comprende buprenorfina
WO2013099835A1 (ja) 2011-12-27 2013-07-04 帝國製薬株式会社 トルテロジン含有貼付剤
EA201592246A1 (ru) 2013-06-04 2016-05-31 Лтс Лохманн Терапи-Системе Аг Трансдермальная система доставки

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
JP3739806B2 (ja) * 1993-05-26 2006-01-25 埼玉第一製薬株式会社 骨格筋弛緩経皮吸収剤
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
JP2000515525A (ja) * 1996-07-19 2000-11-21 アベーグ，グンナー 尿と胃腸の疾患の治療におけるｓ（―）―トルテロジン
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
SE9802864D0 (sv) * 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
DE69942928D1 (de) 1998-08-27 2010-12-23 Pfizer Health Ab Therapeutische formulierung zur verabreichung von tolterodin mit kontrollierter freisetzung

Also Published As

Publication number Publication date
CN1356894A (zh) 2002-07-03
ATE335469T1 (de) 2006-09-15
WO2000069421A2 (de) 2000-11-23
AU4921800A (en) 2000-12-05
DE50013305D1 (de) 2006-09-21
PL352057A1 (en) 2003-07-28
ZA200108147B (en) 2002-06-27
PT1178782E (pt) 2006-12-29
DE19922662C1 (de) 2000-12-28
US6783769B1 (en) 2004-08-31
AU772648B2 (en) 2004-05-06
WO2000069421A3 (de) 2001-03-22
DK1178782T3 (da) 2006-12-11
BR0010618A (pt) 2002-02-19
RU2251413C2 (ru) 2005-05-10
CA2373629A1 (en) 2000-11-23
HK1047703A1 (zh) 2003-03-07
NO20015614D0 (no) 2001-11-16
EP1178782A2 (de) 2002-02-13
JP2002544222A (ja) 2002-12-24
ES2270832T3 (es) 2007-04-16
MXPA01011536A (es) 2003-09-10
EP1178782B1 (de) 2006-08-09

Similar Documents

Publication Publication Date Title
NO20015614D0 (no) Transdermalt terapeutisk system (TTS) som inneholder tolterodin
NO20004859D0 (no) Transdermale, terapeutiske systemer (TTS) inneholdende pergolid
DK1063983T3 (da) Transdermalt terapeutisk system (TTS) indeholdende oxybutynin
ATE212234T1 (de) Hormonpflaster
DE69527296D1 (de) Cyanacrylat klebstoffzusammensetzung
WO1999012529A3 (de) Transdermales therapeutisches system mit haftklebender reservoirschicht und unidirektional elastischer rückschicht
DE59308413D1 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
DE59807891D1 (de) Transdermales therapeutisches system (tts) enthaltend ammoniogruppenhaltige (meth)acrylatpolymere zur verabreichung von levonorgestrel
ATE395050T1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
FI971711A0 (fi) Levobupivakaiinin ja sen analogien kiteyttäminen
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
IT1297139B1 (it) Composizioni per la somministrazione transdermica e dermica di sostanze biologicamente attive
DK0804176T3 (da) Transdermal indgivelsesform af nitroglycerin til forhindring af uønskede veer
MX9707868A (es) La triacetina como incrementador de penetracion transdermica.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application